Head to head comparison of Prasugrel versus Ticagrelor in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized trials

Table 4 Results of this analysis

Outcomes analyzed	No of studies involved	OR with 95% CI	P value	I² (%)
Mortality	4	1.52 [0.42 – 5.45]	0.52	0
MI	2	0.59 [0.08 – 4.58]	0.62	0
MACEs	4	0.91 [0.37 – 2.21]	0.83	0
Stroke	3	0.60 [0.08 – 4.58]	0.62	0
ST	2	0.59 [0.08 – 4.58]	0.62	0
Any bleeding	4	1.30 [0.64 – 2.64]	0.47	37
TIMI minor bleeding	2	3.11 [0.48 – 19.94]	0.23	1
TIMI minimal bleeding	2	2.39 [0.35 – 16.42]	0.38	0
BARC defined bleeding	2	0.92 [0.39 – 2.13]	0.84	0

Abbreviations: MI myocardial infarction, MACEs major adverse cardiac events, ST stent thrombosis, TIMI thrombolysis in myocardial infarction, BARC bleeding defined by the academic research consortium, OR odds ratios, CI confidence intervals

ISSN: 2050-6511